TL;DR
- Humoral immunity works through molecules dissolved in body fluids — above all antibodies, made by B cells. "Humor" is the old word for a body fluid; that is literally where the name comes from.
- Cellular immunity — cell-mediated immunity — works through cells acting directly on a target. T cells are the defining players, and no antibody is involved.
- The cleaner picture is a 2×2: innate vs. adaptive on one axis, cellular vs. humoral on the other. All four boxes are occupied, and that is where most of the confusion comes from.
- Transfer factor was discovered on the cellular side. Lawrence's founding 1949 paper is titled "The cellular transfer of cutaneous hypersensitivity to tuberculin in man" — a delayed-type hypersensitivity response, which is cell-mediated by definition.
- The published work on the 4Life Transfer Factor Max formula measured cellular and innate markers — immune surveillance, neutrophil activation, stem cell mobilisation. No published study on Max measured antibody levels, and no antibody claim is made here.*
Ask what an immune system is and most people describe a single thing: a defence force, vaguely located, that gets "strong" or "weak." Immunologists do not think about it that way. They think about compartments — separate systems with separate hardware, separate tempos and separate jobs, which happen to be wired together.
The oldest and most useful of those divisions is between humoral and cellular immunity. It is worth knowing for its own sake. It is also the fastest way to tell whether a page about immune supplements is being precise or is simply making noise, because a page that never distinguishes the two is not describing anything specific enough to be checked.
Humoral immunity: defence you could put in a test tube
Humoral immunity is immunity carried by soluble molecules — things dissolved in blood, lymph and other extracellular fluid. The name is a survival from pre-modern medicine, when the body was thought to be governed by four humors, or fluids. The theory is long dead; the word stuck, and it now means something exact: the part of immunity you could, in principle, draw off in a syringe and separate from any living cell.
The stars of the humoral arm are antibodies, also called immunoglobulins. They are Y-shaped proteins produced by B cells, which mature into antibody factories called plasma cells. Humans make five classes — IgG, IgM, IgA, IgE and IgD — and each has a job and a location. IgG dominates the bloodstream and is the class that crosses the placenta. IgA guards mucosal surfaces and is the class concentrated in milk. IgM is the first responder of a brand-new response. IgY, the avian counterpart of IgG, is the reason a hen loads her yolk before the shell closes.
Antibodies do not kill anything by themselves. They label. An antibody binds a specific target, and that binding either neutralises it outright, tags it for a phagocyte to eat, or triggers the complement system — a cascade of blood proteins that can punch holes in bacterial membranes. Complement is itself humoral, and it belongs to the innate side, which is the first hint that "humoral" and "adaptive" are not synonyms.
Cellular immunity: defence that has to show up in person
Cellular immunity, more precisely called cell-mediated immunity, is the arm that operates without antibodies. Its signature players are T cells, and their defining trick is direct contact with a target cell.
Two subsets carry most of the load. CD8+ cytotoxic T cells inspect the surface of the body's own cells, and when a cell displays fragments of something it should not contain, the T cell instructs it to die. CD4+ helper T cells do not kill; they coordinate — releasing cytokines that license macrophages to destroy what they have swallowed, and that direct B cells toward better antibody.
The reason this arm has to exist is a geometry problem. Antibodies are large and they patrol fluid, so they can only reach a threat that is outside a cell. A virus replicating inside one of your own cells, or a bacterium that has taken up residence inside a macrophage, is invisible to the humoral arm. Nothing dissolved in plasma can get to it. Something has to arrive, inspect the cell from the outside, read what it is displaying, and act. That is cellular immunity, and it is why the two arms are not interchangeable.
The 2×2 that fixes the confusion
Most of the muddle around these words comes from collapsing two different axes into one. Innate versus adaptive describes how a defence knows what to hit — inherited pattern recognition, or learned specificity. Cellular versus humoral describes what the defence is physically made of — a cell, or a molecule in fluid. They are independent questions, and every combination exists:
| Cellular — cells acting directly | Humoral — molecules in fluid | |
|---|---|---|
| Innate fast, inherited, general |
Neutrophils, macrophages, dendritic cells, natural killer (NK) cells | Complement proteins, antimicrobial peptides such as defensins, acute-phase proteins, interferons |
| Adaptive slower, learned, specific |
CD4+ helper T cells, CD8+ cytotoxic T cells, memory T cells | Antibodies from B cells and plasma cells; memory B cells that make more of them |
Read the grid and two common errors disappear at once. First, "cellular immunity" does not simply mean "immune cells." Neutrophils are cells, and in the strict sense they are not cellular immunity — they are innate. Second, humoral does not mean weak or secondary. Complement is humoral, and it is one of the oldest defence systems on earth.
Where the vocabulary genuinely breaks down
Two honest caveats, because the textbooks themselves are not perfectly consistent.
NK cells sit awkwardly. Natural killer cells kill by direct contact, exactly like a cytotoxic T cell, so many sources file them under "cell-mediated immunity" in the broad sense of defence carried out by cells. In the strict sense — the adaptive arm defined against the antibody arm — cell-mediated immunity means T cells. Both usages are in print. When someone says "cellular immunity," it is worth knowing which one they mean.
Cytokines are soluble, but they are not the humoral arm. Interleukins, interferons and the rest are signalling molecules dissolved in fluid, which makes them soluble mediators — not antibodies. A study that reports cytokine changes is reporting on communication traffic, not on humoral immunity in the classical sense. That distinction matters directly to the research discussed below.
And the largest caveat of all: the two arms are not rivals. A high-quality, class-switched, high-affinity antibody response is not a purely humoral achievement — it requires CD4+ helper T cells inside the lymph node directing the B cells that produce it. Remove the cellular arm and the humoral arm degrades. They were never separate systems; the split is a description, not a wall.
Which arm was transfer factor discovered in?
Here the vocabulary pays off, because transfer factor has an unusually clear answer — and it is sitting in the title of the founding paper.
In 1949 the physician H. Sherwood Lawrence published "The cellular transfer of cutaneous hypersensitivity to tuberculin in man." He took white blood cells from donors who reacted to tuberculin — people whose immune systems already recognised the tuberculosis antigen — prepared a cell-free, dialysable extract, and gave it to recipients who did not react. The recipients converted. Their skin tests turned positive. Something transferable, small enough to pass a dialysis membrane and not a whole living cell, had carried a specific piece of immune recognition from one person to another.
The response he transferred was delayed-type hypersensitivity — the reaction behind a tuberculin skin test, which swells over 48 to 72 hours rather than in minutes. That delay is the tell. Fast reactions are antibody-driven. A response that takes two or three days to appear is T cells being recruited to the site. Delayed-type hypersensitivity is the textbook readout for cell-mediated immunity, and it is not an antibody phenomenon at all.
So the historical answer is unambiguous: transfer factor entered the scientific literature as a cellular phenomenon. Lawrence used the word in his own title. Later reviews describe transfer factor precisely as a dialysable leukocyte extract capable of transferring delayed-type hypersensitivity from an immune to a non-immune individual. That is the record.
The vocabulary, in one place
- Humoral immunity
- Defence carried by soluble molecules in body fluids — antibodies above all, plus complement and antimicrobial peptides. From humor, an old word for body fluid.
- Cellular immunity
- Also cell-mediated immunity. Defence carried out by cells acting directly on targets, without antibodies. Strictly: T cells. Broadly: any cell that kills or eats.
- B cell
- The adaptive cell that matures into a plasma cell and secretes antibody. The humoral arm's producer.
- T cell
- The adaptive cell that inspects and instructs. CD8+ kills infected cells; CD4+ coordinates everything else, including the antibody response.
- Delayed-type hypersensitivity
- A T-cell-driven skin reaction peaking at 48–72 hours. The classic laboratory readout for cell-mediated immunity — and the response Lawrence transferred in 1949.
- Innate vs. adaptive
- A different axis entirely: how a defence recognises a threat. Innate is inherited and general; adaptive is learned and specific. Both have cellular and humoral components.
What the modern research on Max actually measured
It is one thing to note where a molecular class was discovered seventy-seven years ago. It is another to say what has been measured recently on a specific finished product — and the two should never be blurred.
Three pieces of work sit behind 4Life's statements about Transfer Factor Max. The peer-reviewed 2024 paper by Yu and colleagues examined immune-related biomarkers relating to rapid immune surveillance, and cytokine changes, after a single dose. Gardner (2026) examined mobilisation of immune stem cells. Jensen (2026), in Clinical Report 058-010, examined neutrophil activation.*
Place those three on the grid above and the pattern is plain. Immune surveillance, stem cell mobilisation, neutrophils — every one of those endpoints sits in the cellular column, and mostly in the innate row. Cytokines are soluble signals, not antibodies. None of the three measured antibody titres.*
That absence deserves to be stated plainly rather than glossed over, because it cuts both ways. It means nobody can honestly tell you this formula "boosts your antibodies" — that endpoint was not tested. It also means nobody can tell you it does not, because an untested question has no answer. The correct description of the published record is narrow: laboratory markers on the cellular and innate side of the grid, measured on the finished formula, in small studies.*
What this article does not claim
- Lawrence's material is not this product. The 1949 experiments used dialysable extracts of human white blood cells given to human recipients. A dietary supplement made from cow colostrum, chicken egg yolk and Brassica napus seed is a different material in a different context. The history explains where the term comes from; it does not carry over to a supplement bottle.
- Biomarkers are not outcomes. A measurable change in a laboratory marker is not the same thing as a change in health, illness or disease risk. The Max studies measured markers.*
- No arm is being claimed here. Nothing on this page asserts that Transfer Factor Max supports cellular immunity, humoral immunity, or any specific immune function in you.
- "Modulate" is not a loophole. Whichever verb is used, a dietary supplement is not intended to diagnose, treat, cure or prevent any disease — and the vocabulary in this article does not change that.*
- The grid is a teaching tool. Real immunology is denser than a 2×2: gamma-delta T cells, innate lymphoid cells, mucosal immunity and immune tolerance all complicate the picture. This is a map, not the territory.
One last connection is worth making. The line this site is built on — Recognize. Respond. Remember. Now renew. — describes properties, not compartments, and memory belongs to both arms. Memory B cells sit on the humoral side; memory T cells sit on the cellular side. An immune system that has learned something has stored that lesson in two different formats, in two different kinds of long-lived cell. Knowing which is which is the difference between a vocabulary and a vibe.
Frequently asked questions
Citations & sources
What this article is built on
- Lawrence, 1949
- H. Sherwood Lawrence, "The cellular transfer of cutaneous hypersensitivity to tuberculin in man," Proceedings of the Society for Experimental Biology and Medicine, 1949. The founding description of transfer factor as a dialysable, cell-free leukocyte extract capable of transferring delayed-type hypersensitivity from an immune to a non-immune individual. Source of this article's statement that transfer factor was characterised as a cellular phenomenon, and of the paper's verbatim title.
- Standard immunology reference
- The humoral / cell-mediated division, the five human immunoglobulin classes, CD4+ and CD8+ T cell function, the complement cascade, the innate–adaptive axis and the 48–72 hour timing of delayed-type hypersensitivity are consensus textbook immunology, not proprietary or product-specific claims. The 2×2 grid is a teaching device assembled here, not a citation.
- Yu et al., 2024
- Yu, L.; Iloba, I.; Cruickshank, D.; Jensen, G.S. "Feasibility Trial Exploring Immune-Related Biomarkers Pertaining to Rapid Immune Surveillance and Cytokine Changes after Consuming a Nutraceutical Supplement Containing Colostrum- and Egg-Based Low-Molecular-Weight Peptides." Current Issues in Molecular Biology, 2024, 46, 6710–6724. Peer-reviewed; measured immune-related biomarkers on a finished formula, not disease outcomes. No antibody titre endpoint.
- Gardner, 2026 · Jensen, 2026
- Clinical work on immune stem cell mobilisation and on neutrophil activation (Clinical Report 058-010), conducted on the Transfer Factor Max formula. Laboratory immune markers on the whole formula. Neither study measured antibody production, and no arm-specific effect is attributed to any single ingredient.
- 4Life product facts
- 4Life Research USA, LLC published product material. Source of the 900 mg per daily serving figure for Transfer Factor Max, the 600 mg Tri-Factor® total, the 300 mg PhytoFactor™ addition and the four-source composition. No pricing is stated on this page.
- What is deliberately absent
- No antibody, immunoglobulin or titre claim is made for any product mentioned. No named T cell, B cell or NK cell effect is attributed to any product. Where the published record is silent, this article says so rather than filling the gap.
Keep reading
What is a transfer factor?
The molecular class itself — what it is, where it comes from, and why "small" is the defining property.
Neutrophils & innate immunity
The most numerous white blood cell you have, and the compartment the Jensen work measured.
What are immune stem cells?
Before a cell can defend anything it has to be made. The precursor story behind both arms.
*These statements have not been evaluated by the Food and Drug Administration. Transfer Factor Max and the other products mentioned are dietary supplements and are not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. This article is general education about immunology and is not medical advice. Follow label directions; do not exceed the recommended daily amount. Consult your healthcare provider before beginning any new supplement program, particularly if you take medication, have an egg or dairy allergy, or are pregnant or nursing.